Scope and Venue Fit (jacs-scope-fit)
When to trigger
- You are unsure JACS is the right home versus a subfield ACS journal
- A co-author says "this is JACS-level" and you want a sober test
- An editor desk-rejected a prior version for "insufficient general interest"
- You must choose Article vs Communication early
The JACS bar (broad interest + rigor)
JACS publishes a significant chemical advance of broad interest across
chemistry, fully supported by data. Two tests must both pass:
-
Advance test — Is the result genuinely new and important, not incremental?
A new reaction/bond construction, a new mechanism or principle, a new
material/property, a new method that others will adopt, or a problem long
considered hard that you solved.
-
Breadth test — Will chemists outside your immediate subfield care?
Generality (scope), conceptual insight, or enabling utility are the usual
sources of breadth.
If only the advance test passes but breadth is narrow, a specialized journal is
the honest fit.
Venue decision table
| Situation |
Likely better venue |
| Broad, general-interest advance, fully supported |
JACS (Article or Communication) |
| Solid methodology, mainly of interest within organic synthesis |
Org. Lett. / J. Org. Chem. |
| Coordination/main-group/bioinorganic, subfield interest |
Inorg. Chem. |
| Catalysis-focused, mechanism within catalysis community |
ACS Catal. |
| Materials synthesis/properties, materials audience |
Chem. Mater. / ACS Nano |
| Physical-chemistry measurement, PC audience |
J. Phys. Chem. family |
| Incremental scope extension of a known reaction |
Specialized journal, not JACS |
Verify current sister-journal scopes on the ACS site; portfolios evolve.
Format fit (set expectations early)
-
Communication — a complete, urgent, high-impact advance that can stand on
concise evidence (full proof lives in the SI). Choose when timeliness and a
clean central result dominate.
-
Article — a full account with complete scope, controls, and mechanism.
Choose when the story needs tables of scope, multiple mechanistic probes, or
several characterized systems.
- Confirm current article types and limits on the JACS author page; hand sizing
to
jacs-length-management.
Naming the breadth driver (be specific)
Editors triage on whether the manuscript itself argues breadth. Pick one primary
driver and make the abstract carry it:
| Breadth driver |
What must be in the data |
Example framing |
| Generality |
Scope spanning substrate classes others use daily; failures disclosed |
"…across ethers, amines, and three drug scaffolds" |
| Concept / mechanism |
A principle transferable beyond the system (new elementary step, selectivity model) |
"…establishes ligand-controlled distal selectivity as a design rule" |
| Enabling utility |
Something practitioners can now do (a disconnection, a probe, a material function) |
"…renders the C(sp³)–F disconnection strategic in route design" |
| Long-standing problem |
Documented prior failures by others; your data closing the gap |
"…solves the site-selectivity problem posed since [prior art]" |
If you cannot fill the middle column from your own data, the driver is aspirational
— either gather the missing evidence or pivot venue now, before writing.
Worked micro-example (same chemistry, two pitches)
-
Subfield pitch (belongs at Org. Lett.): "We extend Ni-catalyzed
hydroamination to six new pyrazole nucleophiles in 61–88% yield."
-
JACS pitch (only if the data back it): "A single Ni catalyst couples any
N–H heterocycle class we tested (5 azole families, 31 examples) with
unactivated olefins, and kinetics reveal why: turnover-limiting olefin
insertion is insensitive to azole pKa — a generality mechanism, not a scope
accident."
The second pitch is honest only when the kinetics and the five-family scope
exist. The scope-fit call is therefore a data audit, not a wording exercise.
Desk-rejection signals worth heeding
- Your own abstract needs a subfield term (e.g., a niche ligand class) to state
why the result matters — the breadth case has not been made.
- The closest peer papers you can cite are all in specialized journals, none in
JACS from the past few volumes.
- The advance sentence begins "We extend / We also / We further" — extension
language reads as incremental at a flagship venue.
Checklist
Anti-patterns
- Equating "lots of work" with "broad interest" — effort is not significance
- "First example of X in our hands" framed as a field-wide first
- Pitching an incremental substrate-scope paper as a conceptual advance
- Choosing Communication when the central claim actually needs full Article-level support
Output format
【Advance】one-sentence statement of the new chemistry
【Breadth source】generality / concept / enabling utility
【Verdict】JACS-fit / better at <named ACS journal>
【Format】Article / Communication (+ reason)
【Next】jacs-results-framing (if JACS-fit) or pivot venue
Related resources
